YU107692A - Sulfonamidi i postupak za njihovo dobijanje - Google Patents

Sulfonamidi i postupak za njihovo dobijanje

Info

Publication number
YU107692A
YU107692A YU107692A YU107692A YU107692A YU 107692 A YU107692 A YU 107692A YU 107692 A YU107692 A YU 107692A YU 107692 A YU107692 A YU 107692A YU 107692 A YU107692 A YU 107692A
Authority
YU
Yugoslavia
Prior art keywords
sulphonimidamide
compounds
sulfonamides
procedure
production
Prior art date
Application number
YU107692A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
J.E. Ray
J.E. Toth
Original Assignee
Elililly And Company Lilly Corporate Center Indianapolis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elililly And Company Lilly Corporate Center Indianapolis filed Critical Elililly And Company Lilly Corporate Center Indianapolis
Publication of YU107692A publication Critical patent/YU107692A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C07C381/10Compounds containing sulfur atoms doubly-bound to nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU107692A 1991-12-20 1992-12-16 Sulfonamidi i postupak za njihovo dobijanje YU107692A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81225991A 1991-12-20 1991-12-20

Publications (1)

Publication Number Publication Date
YU107692A true YU107692A (sh) 1995-12-04

Family

ID=25209033

Family Applications (1)

Application Number Title Priority Date Filing Date
YU107692A YU107692A (sh) 1991-12-20 1992-12-16 Sulfonamidi i postupak za njihovo dobijanje

Country Status (17)

Country Link
EP (1) EP0552553B1 (https=)
JP (1) JP3202373B2 (https=)
AU (1) AU654069B2 (https=)
BR (1) BR9205020A (https=)
CA (1) CA2085297A1 (https=)
CZ (1) CZ365392A3 (https=)
DE (1) DE69221114T2 (https=)
ES (1) ES2104857T3 (https=)
FI (1) FI925693A7 (https=)
HU (1) HUT65746A (https=)
IL (1) IL104088A0 (https=)
MX (1) MX9207264A (https=)
NO (1) NO924848L (https=)
NZ (1) NZ245458A (https=)
TW (1) TW221049B (https=)
YU (1) YU107692A (https=)
ZA (1) ZA929699B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS65492B1 (sr) * 2017-07-24 2024-05-31 Novartis Ag Jedinjenja i kompozicije za lečenje stanja povezanih sa aktivnošću nlrp
CN111094242B (zh) * 2017-07-24 2024-02-09 诺华股份有限公司 用于治疗与nlrp活性相关的病症的化合物和组合物
US11623922B2 (en) 2017-10-03 2023-04-11 Inflazome Limited Compounds
CN112654350A (zh) * 2018-07-03 2021-04-13 诺华股份有限公司 使用nlrp3拮抗剂治疗对tnf抑制剂有抗性的受试者或针对所述患者选择治疗的方法
EP3880666B1 (en) 2018-11-13 2023-06-28 Novartis AG Compounds and compositions for treating conditions associated with nlrp activity
CN113015730A (zh) 2018-11-13 2021-06-22 诺华股份有限公司 用于治疗与nlrp活性相关的病症的化合物和组合物
US20230059136A1 (en) * 2018-11-16 2023-02-23 Novartis Ag The compounds and compositions for treating conditions associated with nlrp activity
WO2021002887A1 (en) * 2019-07-02 2021-01-07 Novartis Inflammasome Research, Inc. Gut-targeted nlrp3 antagonists and their use in therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666506A (en) 1984-08-08 1987-05-19 E. I. Du Pont De Nemours And Company Herbicidal pyrimidines
IL83215A (en) * 1986-07-23 1991-12-15 Lilly Co Eli Synthesis of bicyclic heteroaromatic sulfonyl chlorides
US5187189A (en) * 1991-01-22 1993-02-16 American Home Products Corporation S-aminoalkyl-s-arylsulfoximines as antiarrhythmic agents
US5140026A (en) * 1991-05-09 1992-08-18 A. H. Robins Company, Incorporated N-aminoalkyl-S-aryl-S-alkyl (or substituted alkyl) sulfoximines as antiarrhythmic agents

Also Published As

Publication number Publication date
CA2085297A1 (en) 1993-06-21
NZ245458A (en) 1995-04-27
NO924848L (no) 1993-06-21
EP0552553B1 (en) 1997-07-23
JPH05345756A (ja) 1993-12-27
EP0552553A1 (en) 1993-07-28
AU654069B2 (en) 1994-10-20
MX9207264A (es) 1993-12-01
BR9205020A (pt) 1993-06-22
NO924848D0 (no) 1992-12-15
HUT65746A (en) 1994-07-28
FI925693A7 (fi) 1993-06-21
DE69221114D1 (de) 1997-08-28
JP3202373B2 (ja) 2001-08-27
TW221049B (https=) 1994-02-11
DE69221114T2 (de) 1997-12-11
AU3018192A (en) 1993-06-24
ES2104857T3 (es) 1997-10-16
HU9203971D0 (en) 1993-04-28
FI925693A0 (fi) 1992-12-15
IL104088A0 (en) 1993-05-13
ZA929699B (en) 1994-06-14
CZ365392A3 (en) 1993-10-13

Similar Documents

Publication Publication Date Title
BG106095A (bg) Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
YU74292A (sh) Jedinjenja za inhibiciju hiv i srodnih virusa
SE8602723L (sv) Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem
AR012588A1 (es) UN INHIBIDOR DE SERINA PROTEASA, UNA COMPOSICIoN FARMACEUTICA QUE LO COMPRENDE Y UN PROCEDIMIENTO PARA PREPARAR UNA COMPOSICIoN FARMACEUTICA
SE9504661D0 (sv) New compounds
MY132705A (en) Novel compounds with analgesic effect
NO20040096L (no) Taxol-forbedringsforbindelser
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
IS1664B (is) Ný aðferð við að framleiða útskipt 4-fenýl-4-píperídínkarboxamíð sem hefur bæði staðbundin deyfandiog kvalastillandi áhrif
ES2173858T3 (es) Analogos de huperzina a.
EP0664128A4 (en) PHARMACEUTICAL AGENT FOR INHIBITING TUMORNESCROSE FACTOR PRODUCTION.
SE9802206D0 (sv) Novel compounds
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ES2060173T3 (es) Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
YU107692A (sh) Sulfonamidi i postupak za njihovo dobijanje
ATE319715T1 (de) Antikonvulsive pseudofructopyranose sulfamate
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto
IT1241079B (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
SE9504662D0 (sv) New compounds
YU44392A (sh) Postupak za dobijanje farmaceutske formulacije diritromicina